Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HMGB2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | LDLRAD2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | TCP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | SRPK1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | GTF3C4 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | MCM6 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PIAS4 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | TGS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | RP11-613M10.8 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | KIFC1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |